58 related articles for article (PubMed ID: 8690901)
1. A combination of IL-10 and direct contact with plasma cell tumors decreases CD23 expression on splenic B cells.
Ruzek MC; Billadeau D; Mathur A
J Immunol; 1996 Mar; 156(6):2124-32. PubMed ID: 8690901
[TBL] [Abstract][Full Text] [Related]
2. Plasma cells tumors decrease CD23 mRNA expression in vivo in murine splenic B cells.
Ruzek MC; Mathur A
Eur J Immunol; 1995 Aug; 25(8):2228-33. PubMed ID: 7664786
[TBL] [Abstract][Full Text] [Related]
3. Immune dysfunction in mice with plasmacytomas. I. Evidence that transforming growth factor-beta contributes to the altered expression of activation receptors on host B lymphocytes.
Berg DJ; Lynch RG
J Immunol; 1991 Apr; 146(8):2865-72. PubMed ID: 1826699
[TBL] [Abstract][Full Text] [Related]
4. Down-regulation of IL-12, not a shift from a T helper-1 to a T helper-2 phenotype, is responsible for impaired IFN-gamma production in mammary tumor-bearing mice.
Handel-Fernandez ME; Cheng X; Herbert LM; Lopez DM
J Immunol; 1997 Jan; 158(1):280-6. PubMed ID: 8977200
[TBL] [Abstract][Full Text] [Related]
5. Regulation of CD23 expression by IL-4 and corticosteroid in human B lymphocytes. Altered response after EBV infection.
Paterson RL; Or R; Domenico JM; Delespesse G; Gelfand EW
J Immunol; 1994 Mar; 152(5):2139-47. PubMed ID: 8133030
[TBL] [Abstract][Full Text] [Related]
6. Activation pathways triggered by interleukin-4 in the human plasmacytoma cell line RPMI-8226--differences with resting B lymphocytes.
Lasfar A; Amirand C; Ballini JP; Kolb JP
Eur Cytokine Netw; 1993; 4(3):213-21. PubMed ID: 8218946
[TBL] [Abstract][Full Text] [Related]
7. Adenovirus vector-mediated overexpression of a truncated form of the p65 nuclear factor kappa B cDNA in dendritic cells enhances their function resulting in immune-mediated suppression of preexisting murine tumors.
Lee JM; Mahtabifard A; Yamada R; Crystal RG; Korst RJ
Clin Cancer Res; 2002 Nov; 8(11):3561-9. PubMed ID: 12429647
[TBL] [Abstract][Full Text] [Related]
8. Induction of CD25 expression in human B lymphocytes by pharmacological activators of cellular signalling pathways.
McKay CE; Cushley W
Cytokine; 1996 Apr; 8(4):305-12. PubMed ID: 9162220
[TBL] [Abstract][Full Text] [Related]
9. Specific antagonism of type I IL-4 receptor with a mutated form of murine IL-4.
Schnare M; Blum H; Jüttner S; Röllinghoff M; Gessner A
J Immunol; 1998 Oct; 161(7):3484-92. PubMed ID: 9759868
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of Kit expression by IL-4 and IL-10 in murine mast cells: role of STAT6 and phosphatidylinositol 3'-kinase.
Mirmonsef P; Shelburne CP; Fitzhugh Yeatman C; Chong HJ; Ryan JJ
J Immunol; 1999 Sep; 163(5):2530-9. PubMed ID: 10452990
[TBL] [Abstract][Full Text] [Related]
11. Regulation of cell morphology in B lymphocytes by IL-4: evidence for induced cytoskeletal changes.
Davey EJ; Thyberg J; Conrad DH; Severinson E
J Immunol; 1998 Jun; 160(11):5366-73. PubMed ID: 9605136
[TBL] [Abstract][Full Text] [Related]
12. Retinoic acid inhibits CD40 plus IL-4 mediated IgE production through alterations of sCD23, sCD54 and IL-6 production.
Scheffel F; Heine G; Henz BM; Worm M
Inflamm Res; 2005 Mar; 54(3):113-8. PubMed ID: 15883744
[TBL] [Abstract][Full Text] [Related]
13. B cells regulate CD40 ligand-induced IL-12 production in antigen-presenting cells (APC) during T cell/APC interactions.
Maruo S; Oh-hora M; Ahn HJ; Ono S; Wysocka M; Kaneko Y; Yagita H; Okumura K; Kikutani H; Kishimoto T; Kobayashi M; Hamaoka T; Trinchieri G; Fujiwara H
J Immunol; 1997 Jan; 158(1):120-6. PubMed ID: 8977182
[TBL] [Abstract][Full Text] [Related]
14. Mouse IL-13 enhances antibody production in vivo and acts directly on B cells in vitro to increase survival and hence antibody production.
Lai YH; Mosmann TR
J Immunol; 1999 Jan; 162(1):78-87. PubMed ID: 9886372
[TBL] [Abstract][Full Text] [Related]
15. Tumor cells engineered to express interleukin-6 exhibit a reduced tumorigenicity depending on the tumor cell model.
Ledda MF; Adris S; Bravo AI; Bover L; Carbone C; Paleolog E; Mordoh J; Chernajovsky Y; Podhajcer OL
Cell Mol Biol (Noisy-le-grand); 1996 Jul; 42(5):769-78. PubMed ID: 8832108
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-10 reduces natural killer sensitivity and downregulates MHC class I expression on H-ras-transformed cells.
Tsuruma T; Yagihashi A; Torigoe T; Sato N; Kikuchi K; Watanabe N; Hirata K
Cell Immunol; 1998 Mar; 184(2):121-8. PubMed ID: 9630838
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-10 secreted by B-1 cells modulates the phagocytic activity of murine macrophages in vitro.
Popi AF; Lopes JD; Mariano M
Immunology; 2004 Nov; 113(3):348-54. PubMed ID: 15500621
[TBL] [Abstract][Full Text] [Related]
18. Transcription factor Egr-1 activity down-regulates Fas and CD23 expression in B cells.
Dinkel A; Aicher WK; Haas C; Zipfel PF; Peter HH; Eibel H
J Immunol; 1997 Sep; 159(6):2678-84. PubMed ID: 9300687
[TBL] [Abstract][Full Text] [Related]
19. Tumor-induced dysfunction in interleukin-2 production and interleukin-2 receptor signaling: a mechanism of immune escape.
Rayman P; Uzzo RG; Kolenko V; Bloom T; Cathcart MK; Molto L; Novick AC; Bukowski RM; Hamilton T; Finke JH
Cancer J Sci Am; 2000 Feb; 6 Suppl 1():S81-7. PubMed ID: 10685665
[TBL] [Abstract][Full Text] [Related]
20. An accessory role for B cells in the IL-12-induced activation of resting mouse NK cells.
Haddad EA; Senger LK; Takei F
J Immunol; 2009 Sep; 183(6):3608-15. PubMed ID: 19710462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
